Largest-Ever Database To Track Global Burden Of Atrial Fibrillation

The London-based Thrombosis Research Institute has announced the launch of a worldwide research initiative that will compile comprehensive information about the global burden of atrial fibrillation (AF). The six-year Global Anticoagulant Registry in the Field (GARFIELD) registry will prospectively track 50,000 patients with newly diagnosed AF who are candidates for chronic anticoagulation therapy with vitamin K antagonists.